BioNano Genomics's total assets for Q1 2026 were $64.80M, a decrease of -11.93% from the previous quarter. BNGO total liabilities were $27.34M for the fiscal quarter, a -6.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.